FAST Research Grants (rolling submissions)

About this program

FAST (Foundation for Angelman Syndrome Therapeutics) funds translational research to accelerate development of therapies for Angelman syndrome, supporting projects across the drug-development spectrum via multiple award mechanisms (FAST‑TRAC, New Investigator, FAST IMPACT, Postdoctoral Fellowship, Innovation Seed, etc.). Applications are accepted on a rolling basis with no fixed deadline, enabling rapid review and funding of promising bench‑to‑bedside work. Eligibility depends on the specific award—programs cover a range of career stages (postdoctoral, new investigators, established researchers) and generally require a focus on Angelman syndrome; consult individual grant descriptions for detailed criteria. For questions or to apply, contact science@cureangelman.org.